SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Personalized Medicine: Molecular Dx
An SI Board Since December 2008
Posts SubjectMarks Bans
60 14 0
Emcee:  rkrw Type:  Unmoderated
Introduction Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10The DNA CP was a little self serving. Fundamentally what they'd like to see rkrw-12/31/2008
9On the regulatory control: Activity in the field has picked up pace and in time idos-12/31/2008
8Apparently they are treated differently. I think it's the reality of the srkrw-12/29/2008
7<i>a cancer connected to asbestos exposure, from other carcinomas in the lSteve Lokness-12/29/2008
6Press Release Source: Rosetta Genomics Ltd Rosetta Genomics Announces Commercirkrw-12/29/2008
5Not suggesting it will always be possible, not even close, but when possible, a rkrw-12/28/2008
4Forbes article apropos to the topic of this board: siliconinvestor.comDewDiligence_on_SI-12/28/2008
3The promise is starting to catch on, selectively. Kras testing for erbitux was hrkrw-12/27/2008
2<i>and it has the potential to transform the effectiveness of medical careSteve Lokness-12/27/2008
1This is just an editorial: boston.com The great promise of personalized medirkrw-12/27/2008
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News